UNSPSC 51402403: Azacyclonol hydrochloride

This classification denotes an anxiolytic with the molecular formula C18H21NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4BXX0XNP9R, chemically known as 4-piperidinemethanol, alpha,alpha-diphenyl-, hydrochloride but more generally known as azacyclonol hydrochloride, which bears US NIH Compound Identifier 15722. European Medicines Agency schedules Azacyclonol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00635MIG.

Most nations, for tariff and trade purposes, schedule azacyclonol hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, AZACYCLONOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Azacyclonol hydrochloride bears US NLM identifiers UMLS ID C0959907 and NCI Concept Code C76503. SMILES: C1CCC(CC1)C(C2CCCCC2)(C3CCNCC3)O.CL.

UNSPSC 51402403 Azacyclonol hydrochloride is a Commodity code that in practice captures pharmaceuticals and active pharmaceutical ingredients procured by state and local health agencies, though recent solicitation activity under this code is sparse. The single recent opportunity on record reflects procurement of naloxone and drug deactivation systems for community health support rather than azacyclonol specifically, indicating potential misclassification or that the code encompasses a broader family of pharmaceutical products and harm-reduction materials than the narrow commodity name suggests. State and local health departments and county public health agencies are the primary issuing bodies when activity does occur under codes in this pharmaceutical range, typically supporting emergency response, community health initiatives, or controlled-substance management programs.

Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. The procurement requires vendors to include all shipping and delivery costs, maintain specified insurance coverages including workers' compensation and commercial general liability, comply with E-Verify requirements, and accept a three-month probationary termination clause. The contract was structured for a two-year initial term with a one-year renewal option and potential FEMA funding. Beyond this single Florida solicitation, the source records no additional recent state and local opportunities under this code, suggesting either minimal procurement volume or continued classification misalignment between the UNSPSC taxonomy and actual purchasing activity in pharmaceutical harm-reduction and community health support.